Isabel García-García1, Yashar Zeighami2, Alain Dagher2. 1. Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, QC, H3A 2B4, Canada. isabel.garciagarcia@mail.mcgill.ca. 2. Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, QC, H3A 2B4, Canada.
Abstract
PURPOSE OF REVIEW: Surprises are important sources of learning. Cognitive scientists often refer to surprises as "reward prediction errors," a parameter that captures discrepancies between expectations and actual outcomes. Here, we integrate neurophysiological and functional magnetic resonance imaging (fMRI) results addressing the processing of reward prediction errors and how they might be altered in drug addiction and Parkinson's disease. RECENT FINDINGS: By increasing phasic dopamine responses, drugs might accentuate prediction error signals, causing increases in fMRI activity in mesolimbic areas in response to drugs. Chronic substance dependence, by contrast, has been linked with compromised dopaminergic function, which might be associated with blunted fMRI responses to pleasant non-drug stimuli in mesocorticolimbic areas. In Parkinson's disease, dopamine replacement therapies seem to induce impairments in learning from negative outcomes. The present review provides a holistic overview of reward prediction errors across different pathologies and might inform future clinical strategies targeting impulsive/compulsive disorders.
PURPOSE OF REVIEW: Surprises are important sources of learning. Cognitive scientists often refer to surprises as "reward prediction errors," a parameter that captures discrepancies between expectations and actual outcomes. Here, we integrate neurophysiological and functional magnetic resonance imaging (fMRI) results addressing the processing of reward prediction errors and how they might be altered in drug addiction and Parkinson's disease. RECENT FINDINGS: By increasing phasic dopamine responses, drugs might accentuate prediction error signals, causing increases in fMRI activity in mesolimbic areas in response to drugs. Chronic substance dependence, by contrast, has been linked with compromised dopaminergic function, which might be associated with blunted fMRI responses to pleasant non-drug stimuli in mesocorticolimbic areas. In Parkinson's disease, dopamine replacement therapies seem to induce impairments in learning from negative outcomes. The present review provides a holistic overview of reward prediction errors across different pathologies and might inform future clinical strategies targeting impulsive/compulsive disorders.
Authors: Alexxai V Kravitz; Benjamin S Freeze; Philip R L Parker; Kenneth Kay; Myo T Thwin; Karl Deisseroth; Anatol C Kreitzer Journal: Nature Date: 2010-07-07 Impact factor: 49.962
Authors: I García-García; A Horstmann; M A Jurado; M Garolera; S J Chaudhry; D S Margulies; A Villringer; J Neumann Journal: Obes Rev Date: 2014-09-29 Impact factor: 9.213
Authors: Katherine R Marks; David N Kearns; Chesley J Christensen; Alan Silberberg; Stanley J Weiss Journal: Behav Brain Res Date: 2010-04-08 Impact factor: 3.332
Authors: Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; Jean Logan; Anna-Rose Childress; Millard Jayne; Yeming Ma; Christopher Wong Journal: J Neurosci Date: 2006-06-14 Impact factor: 6.167
Authors: Jessica S Flannery; Michael C Riedel; Katherine L Bottenhorn; Ranjita Poudel; Taylor Salo; Lauren D Hill-Bowen; Angela R Laird; Matthew T Sutherland Journal: Cogn Affect Behav Neurosci Date: 2020-04 Impact factor: 3.282
Authors: Robert S Eisinger; Morgan E Urdaneta; Kelly D Foote; Michael S Okun; Aysegul Gunduz Journal: Front Neurosci Date: 2018-07-05 Impact factor: 4.677
Authors: Emilie Werlen; Soon-Lim Shin; Francois Gastambide; Jennifer Francois; Mark D Tricklebank; Hugh M Marston; John R Huxter; Gary Gilmour; Mark E Walton Journal: Neuropsychopharmacology Date: 2019-11-08 Impact factor: 7.853
Authors: Joseph Aloi; Kathleen I Crum; Karina S Blair; Ru Zhang; Johannah Bashford-Largo; Sahil Bajaj; Amanda Schwartz; Erin Carollo; Soonjo Hwang; Emily Leiker; Francesca M Filbey; Bruno B Averbeck; Matthew Dobbertin; R James R Blair Journal: Dev Cogn Neurosci Date: 2021-03-15 Impact factor: 6.464